HKU Scholars Hub: Browsing DSpace

Browsing by Author Kim, WS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 6 to 15 of 15 < previous

	Title	Author(s)	Issue Date	Views
	Histone H3K27 Demethylase JMJD3 in Cooperation with NF-κB Regulates Keratinocyte Wound Healing Journal:Journal of Investigative Dermatology	Na, J Lee, K Na, W Shin, JY Lee, MJ Yune, TY Lee, HW Jung, HS Kim, WS Ju, BG	2016	78
	Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009 Journal:The Lancet Oncology	Kwong, YL Anderson, BO Advani, R Kim, WS Levine, AM Lim, ST	2009	162
	Nasal natural killer/T-cell lymphoma Book:Extranodal lymphomas: pathology and management	Au, WY Liang, RHS Ko, YH Kim, WS	2008	141
	Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia Journal:Cancer Science	Yamaguchi, M Suzuki, R Kwong, YL Kim, WS Hasegawa, Y Izutsu, K Suzumiya, J Okamura, T Nakamura, S Kawa, K Oshimi, K	2008	168
	Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal Natural Killer (NK)/T-cell lymphoma, nasal type: The NK-cell tumor study group study Journal:Journal of Clinical Oncology	Yamaguchi, M Kwong, YL Kim, WS Maeda, Y Hashimoto, C Suh, C Izutsu, K Ishida, F Isobe, Y Sueoka, E Suzumiya, J Kodama, T Kimura, H Hyo, R Nakamura, S Oshimi, K Suzuki, R	2011
	Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis Journal:The Lancet Haematology	Kim, SJ Choi, JY Hyun, SH Ki, CS Oh, D Ahn, YC Ko, YH Choi, S Jung, SH Khong, PL Tang, T Yan, X Lim, ST Kwong, YL Kim, WS Asia Lymphoma Study Group	2015	58
	SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group Journal:Blood	Kwong, YL Kim, WS Lim, ST Kim, SJ Tang, T Tse, EWC Leung, AYH Chim, JCS	2012
	Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group Journal:Journal of Hematology & Oncology	Yoon, DH Cao, J Chen, TY Izutsu, K Kim, SJ Kwong, YL Lin, TY Thye, LS Xu, B Yang, DH Kim, WS	2020	17
	Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group Journal:American Journal of Hematology	Tse, E Gill, H Loong, F Kim, SJ NG, SB Tang, T Ko, YH Chng, WJ Lim, ST Kim, WS Kwong, YL	2012	183
	Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma Journal:Leukemia	Lim, JQ Huang, D Tang, T Tan, D Laurensia, Y Peng, RJ Wong, EKY Cheah, DMZ Chia, BKH Iqbal, J Grigoropoulos, NF Nairismägi, ML Ng, CCY Rajasegaran, V Hong, H Kim, SJ Cho, J Tse, E Mow, B Cai, QC Poon, LM Cai, QQ Tan, J Chan, JY Lim, JX Goh, YT Phipps, C Rötzschke, O Cheng, CL Ha, JCH Khoo, LP Loh, YSM Au Yeung, R Chan, TSY Kwong, YL Hwang, W Kim, WS Bei, JX Lin, T Ong, CK Lim, ST	2020	48

Showing results 6 to 15 of 15 < previous